Komori
Semi-Annual Report4881FunPep Company LimitedPharmaceuticals

Semi-Annual Report — FY2026 H1

What FunPep Company Limited reported for the period from 2026-01-01 to 2026-12-31.

How much it says
50Typical
What moved here
11named for the first time
Its own wording
31terms
Which filing this is
17/ 17newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

During the current interim consolidated accounting period, the Group recorded business revenue of ¥1,854 thousand from research and development and sales of functional peptides outside pharmaceuticals, while recording an operating loss of ¥538,266 thousand and an interim net loss attributable to owners of the parent of ¥566,956 thousand due to research and development expenses. In terms of funding, financing activities generated cash through the issuance of new shares and other transactions, offsetting cash outflows from operating activities, and cash and cash equivalents stood at ¥1,894,935 thousand at period-end.

Komori's summary of this document, not the document's own words.
50Typical
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
Change intensity
38
Thin
Strategic shift
49
Typical
Capital movements
75
Very detailed
Disclosure Gaps
15
Almost nothing
Future commitments
68
Detailed
Change in Risk
55
Typical
Financial and Capital Policy
13
Almost nothing
Product Portfolio
55
Typical
Technology Position
50
Typical
Confidence in Strategic Bets
R&D spend4億円Money spent making new things.
Cash left over-6億円Cash from the business, less what went into equipment.
Spent on equipment0百万円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
FunPep Company Limited — FY2026 H1 | Komori